Dai Shaodong, Crawford Frances, Marrack Philippa, Kappler John W
Integrated Department of Immunology, Howard Hughes Medical Institute, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11893-7. doi: 10.1073/pnas.0805810105. Epub 2008 Aug 12.
Class II major histocompatibility complex (MHCII) molecules present antigens to CD4(+) T cells. In addition to the most commonly studied human MHCII isotype, HLA-DR, whose beta chain is encoded by the HLA-DRB1 locus, several other isotypes that use the same alpha chain but have beta chains encoded by other genes. These other DR molecules also are expressed in antigen-presenting cells and are known to participate in peptide presentation to T cells and to be recognized as alloantigens by other T cells. Like some of the HLA-DRB1 alleles, several of these alternate DR molecules have been associated with specific autoimmune diseases and T cell hypersensitivity. Here we present the structure of an HLA-DR molecule (DR52c) containing one of these alternate beta chains (HLA-DRB3*0301) bound to a self-peptide derived from the Tu elongation factor. The molecule shares structurally conserved elements with other MHC class II molecules but has some unique features in the peptide-binding groove. Comparison of the three major HLA-DBR3 alleles (DR52a, b, and c) suggests that they were derived from one another by recombination events that scrambled the four major peptide-binding pockets at peptide positions 1, 4, 6, and 9 but left virtually no polymorphisms elsewhere in the molecules.
II类主要组织相容性复合体(MHCII)分子将抗原呈递给CD4(+) T细胞。除了最常研究的人类MHCII同种型HLA-DR(其β链由HLA-DRB1基因座编码)外,还有其他几种同种型,它们使用相同的α链,但β链由其他基因编码。这些其他DR分子也在抗原呈递细胞中表达,已知它们参与向T细胞呈递肽,并被其他T细胞识别为同种抗原。与一些HLA-DRB1等位基因一样,这些替代DR分子中的几种与特定的自身免疫性疾病和T细胞超敏反应有关。在这里,我们展示了一种HLA-DR分子(DR52c)的结构,该分子包含这些替代β链之一(HLA-DRB3*0301),并与源自Tu延伸因子的自身肽结合。该分子与其他MHC II类分子具有结构保守的元件,但在肽结合槽中具有一些独特的特征。对三种主要的HLA-DBR3等位基因(DR52a、b和c)的比较表明,它们是通过重组事件彼此衍生而来的,这些重组事件扰乱了肽位置1、4、6和9处的四个主要肽结合口袋,但在分子的其他位置几乎没有多态性。